Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

[edit this page]

Polidori, C. et al.

Polidori, Ciccocioppo, Nisato, Cazaubon, Massi,

Evaluation of the ability of irbesartan to cross the blood-brain barrier following acute intragastric treatment.

The present study evaluated in functional tests the ability of the angiotensin AT1 receptor antagonist irbesartan, 2-n-butyl-3-[(2'-(1H-tetrazol-5-yl)-biphenyl-4-yl)methyl]-1,3-d iaza-spiro[4,4]non-1-en-4-one, in comparison to losartan, 2-n-butyl-4-chloro-5-hydroxymethyl-1-[(2'(1H-tetrazol-5-yl) bi-phenyl-4-yl)methyl]imidazole, to cross the blood-brain barrier following acute intragastric administration. Two tests were used: the dipsogenic response to intracerebroventricular injection of angiotensin II, and Na+ intake in response to adrenalectomy. In normotensive rats, irbesartan reduced the dipsogenic response to angiotensin II, 10 pmol per rat, at the dose of 90 mg/kg, but not at lower doses. Losartan significantly reduced angiotensin II-induced drinking at 30 mg/kg, but not at a lower dose. In spontaneously hypertensive rats, irbesartan reduced the response to angiotensin II at 50 mg/kg, but not at lower doses, while losartan significantly inhibited angiotensin II-induced drinking even at 10 mg/kg. In adrenalectomized rats, the intake of 2% NaCl was inhibited by the intragastric administration of losartan 30 or 50 mg/kg, while irbesartan did not reduce it in doses up to 50 mg/kg. The results of the present study consistently indicate that after acute intragastric administration, the ability of irbesartan to cross the blood-brain barrier is lower than that of losartan.[1]

References

Evaluation of the ability of irbesartan to cross the blood-brain barrier following acute intragastric treatment. Polidori, C., Ciccocioppo, R., Nisato, D., Cazaubon, C., Massi, M. Eur. J. Pharmacol. (1998) [Pubmed]

Annotations and hyperlinks in this abstract are from individual authors of WikiGenes or automatically generated by the WikiGenes Data Mining Engine. The abstract is from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.About WikiGenes Open Access Licence Privacy Policy Terms of Use apsburg

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.